- Investing.com
Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Metrics to compare | INEG | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipINEGPeersSector | |
---|---|---|---|---|
P/E Ratio | 40.6x | 25.2x | −0.6x | |
PEG Ratio | - | 0.36 | 0.00 | |
Price / Book | 6.4x | 3.4x | 2.6x | |
Price / LTM Sales | 5.6x | 2.8x | 3.1x | |
Upside (Analyst Target) | 9.4% | 17.9% | 55.4% | |
Fair Value Upside | Unlock | −7.9% | 10.2% | Unlock |